DSS, Inc. Announces Launch of Proposed Public Offering

DSS begins a common stock offering under its existing shelf registration to raise capital for general corporate and working capital needs.

Rhea-AI Summary

DSS (DSS) has commenced a proposed public offering of its common stock, with all shares to be issued and sold by the company itself. The offering size and pricing have not yet been disclosed and completion remains subject to market conditions.

DSS plans to use the net proceeds for general corporate and working capital purposes. The common stock trades on the NYSE American under the symbol “DSS”. Aegis Capital Corp. is acting as sole book-running manager on a firm commitment basis. The transaction is being conducted under an effective Form S-3 shelf registration, with a final prospectus supplement to be filed with the SEC.

Positive

• Equity capital raise initiated via a firm commitment underwritten offering
• Proceeds intended for general corporate and working capital needs
• Use of an already effective Form S-3 shelf registration streamlines the process
• Engagement of Aegis Capital Corp. as sole book-running manager provides underwriting support

Negative

• All shares in the offering are newly issued by DSS, implying potential shareholder dilution
• Offering completion, size, and terms are uncertain and subject to market conditions

News Explained

The offering could dilute existing holders, but its share count, price, proceeds, and completion remain undetermined.

DSS has commenced a proposed public offering in which it would issue and sell common shares itself; if completed, that would increase the total share count and reduce existing holders’ percentage ownership, while the amount of dilution is not yet established.

The effective Form S-3 authorizes future sales without a new registration each time, but does not itself sell shares; the final prospectus supplement is expected to state the specific offering’s size, price, and fees.

As of June 30, 2026, DSS reported $4,068,000 of cash, $1,090,000 of short-term investments, and $1,719,000 of long-term investments; together, those holdings equal 337.9 days of the last reported quarterly operating cash use at that rate.

Sources and calculations

• DSS Announces Launch of Proposed Public Offering (2026-09-03)
• Dilution (2026-07-17)
• Form S-3 purpose (2026-07-17)
• Prospectus supplement purpose (2026-07-17)
• DSS second-quarter 2026 fundamentals (2026Q2)

• Available liquidity against the last reported quarterly operating outflow, in days at that rate ($4,068,000 + $1,090,000 + $1,719,000) / ($1,852,000 / 91) = 337.9 days

Market Context

DSS’s prior close was $0.552 before publication, with the stock 70.32% below its 52-week high. The p...

Analysis

DSS’s prior close was $0.552 before publication, with the stock 70.32% below its 52-week high. The proposed offering’s unspecified size left dilution assessment incomplete, while low short positioning remained a relevant risk context.

Key Figures

Registration Statement: No. 333-281974 Shelf Effective Date: November 5, 2024

2 metrics

Registration Statement No. 333-281974 Form S-3

Shelf Effective Date November 5, 2024 SEC-declared effective Form S-3

Previous Offering Reports

3 past events · Latest: Feb 05 (Negative)

Same Type Pattern 3 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 05	Offering closing	Negative	-5.3%	Firm commitment offering closed with $1.0 million in gross proceeds
Feb 04	Offering pricing	Negative	-32.4%	DSS priced 900,000 shares at $1.00 per share
Feb 03	Offering launch	Negative	-32.4%	DSS launched a proposed company-funded common-stock offering

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

DSS offering-related announcements were followed by negative price reactions, with a tag-specific average move of -23.35%.

Key Terms

public offering, shelf registration statement, firm commitment, prospectus supplement

4 terms

public offering financial

"today announced that it has commenced a public offering to offer and sell shares"

A public offering is when a company sells shares to the general public through the stock market, either by issuing new shares to raise cash or by letting existing owners sell their stakes. Think of it like a business opening its doors to many new owners at once: it can bring in money for growth but also increases the number of shares available, which can change the stock price and dilute existing ownership — key factors investors watch closely.

shelf registration statement regulatory

"made pursuant to an effective shelf registration statement on Form S-3"

A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.

firm commitment financial

"acting as the sole book-running manager for the offering on a firm commitment basis"

An underwriting agreement where an investment bank guarantees to buy an entire new issue of securities from an issuer and then resell them to the public. Think of it as a store owner agreeing to buy a whole shipment upfront so the seller gets paid immediately; for investors this matters because it reduces the risk that the offering will fail, sets the initial supply and price pressure in the market, and signals underwriter confidence in selling the shares.

prospectus supplement regulatory

"A final prospectus supplement and accompanying prospectus describing the terms"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced that it has commenced a public offering to offer and sell shares of its Common Stock.

All of the shares of Common Stock are being offered by the Company (the “Offering”).

The Company intends to use the net proceeds from the Offering for general corporate and working capital needs. The Company’s Common Stock is trading on the NYSE American LLC under the symbol “DSS”. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.

Aegis Capital Corp. is acting as the sole book-running manager for the offering on a firm commitment basis.

The offering is being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-281974) previously filed with the U.S. Securities and Exchange Commission (SEC) and declared effective by the SEC on November 5, 2024. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website located at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Aegis Capital Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com, or by telephone at +1 (212) 813-1010.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About DSS, Inc.

DSS, Inc. (NYSE American: DSS) is a multinational company operating across multiple business lines including product packaging, biotechnology, commercial lending, and securities and investment management. The Company operates a business model based on developing high-growth subsidiaries and unlocking value through strategic IPOs and public listings. For more information, visit www.dssworld.com.

Forward-Looking Statements

The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the Company’s product development and business prospects, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. Except as required by applicable law, including the security laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

For investor and media inquiries or additional information, please contact:

Investor Contact:
DSS, Inc.
Investor Relations
ir@dssworld.com
+1 (585) 565-2422

FAQ

What did DSS (DSS) announce regarding its stock on September 3, 2026?

DSS announced that it has commenced a public offering of its common stock, with all shares to be offered and sold by the company, subject to market conditions and final terms to be set in a prospectus supplement.

How will DSS (DSS) use the proceeds from the proposed public offering?

DSS plans to use the net proceeds from the proposed offering for general corporate purposes and working capital needs. No additional, more specific uses of proceeds were detailed in the announcement.

Who is managing the DSS (DSS) proposed public offering?

Aegis Capital Corp. is acting as the sole book-running manager for DSS’s proposed public offering on a firm commitment basis, meaning it has agreed to purchase the offered shares from the company and resell them to investors.

Under what registration is the DSS (DSS) stock offering being made?

The DSS common stock offering is being made under an effective shelf registration statement on Form S-3 (No. 333-281974), which was declared effective by the SEC on November 5, 2024, enabling the company to offer securities more flexibly.

Where can investors find the prospectus for the DSS (DSS) proposed offering?

A final prospectus supplement and accompanying prospectus for the DSS offering will be filed with the SEC and available on www.sec.gov. Electronic copies may also be obtained from Aegis Capital Corp.’s Syndicate Department via mail, email, or telephone as provided.

Is the DSS (DSS) public offering guaranteed to be completed?

No. The DSS public offering is subject to market conditions, and there is no assurance as to whether or when it will be completed, or what the actual size and terms of the offering will be.